A comparison of the pharmacokinetics of propranolol in obese and normal volunteers.
Open Access
- 1 May 1986
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 21 (5) , 529-532
- https://doi.org/10.1111/j.1365-2125.1986.tb02837.x
Abstract
The pharmacokinetics of intravenous and oral propranolol have been compared in six obese and six normal subjects matched for age and sex. After intravenous administration there was no difference in plasma clearance but the volume of distribution was greater (V = 339 l vs 198 l) and the half-life was longer (t1/2 = 5.0 h vs 3.0 h) in the obese group. No important difference in the rate of oral absorption was observed. A trend towards higher systemic availability in the obese group (35% vs 27%) was not statistically significant.This publication has 10 references indexed in Scilit:
- Effect of Age, Gender, and Obesity on Midazolam KineticsAnesthesiology, 1984
- Lidocaine disposition in obesityThe American Journal of Cardiology, 1984
- The Influence of Obesity on the Pharmacokinetics of Oral Alprazolam and TriazolamClinical Pharmacokinetics, 1984
- A sensitive high-pressure liquid chromatographic method for the determination of propranolol in microliter serum samplesChromatographia, 1982
- Pharmacokinetics of Drugs in ObesityClinical Pharmacokinetics, 1982
- Alterations in drug distribution and clearance due to obesity.The Journal of Pharmacology and Experimental Therapeutics, 1981
- Clinical Pharmacokinetics of PropranololClinical Pharmacokinetics, 1979
- Direct measurement of propranolol bioavailability during accumulation to steady-state.Published by Wiley ,1978
- Theophylline disposition in obesityClinical Pharmacology & Therapeutics, 1978
- Data point weighting in pharmacokinetic analysis: intravenous paracetamol in manJournal of Pharmacy and Pharmacology, 1976